AestheticsWorldwide
Weight-loss jabs are changing skincare, says L’Oréal
The world’s biggest beauty company says the boom in GLP-1 weight-loss drugs is already reshaping skincare sales, and it’s developing products for “Ozempic face”.
Updated weekly
The latest in aesthetics, skin, regulation and salon business, from the UK, Europe and around the world.
The world’s biggest beauty company says the boom in GLP-1 weight-loss drugs is already reshaping skincare sales, and it’s developing products for “Ozempic face”.
Korean beauty giant Olive Young says the next big shift is the pursuit of a “complete self”, with treatments and home care joined up.
Market researchers expect worldwide spending on aesthetic injectables to pass $15bn in 2026 and keep growing at around 10% a year.